Brimonidine tartrate
Categorie
Brimonidine tartrate Les marques, Brimonidine tartrate Analogs
Brimonidine tartrate Les marques melange
Brimonidine tartrate Formule chimique
C11H10BrN5
Brimonidine tartrate RX lien
http://www.rxlist.com/cgi/generic3/alphagan-p.htm
Brimonidine tartrate FDA fiche
Brimonidine tartrate msds (fiche de securite des materiaux)
Brimonidine tartrate Synthese de reference
MB Thomas, MT Williams, Ger. Pat. 2.538.630 (1976 à Pfizer)
Brimonidine tartrate Poids moleculaire
292.135 g/mol
Brimonidine tartrate Point de fusion
207.5 oC
Brimonidine tartrate H2O Solubilite
Soluble (1,5 mg / ml)
Brimonidine tartrate Etat
Solid
Brimonidine tartrate LogP
0.782
Brimonidine tartrate Formes pharmaceutiques
Solution à 0,2%
Brimonidine tartrate Indication
Pour l'abaissement de la pression intraoculaire chez les patients avec glaucome à angle ouvert ou d'hypertension oculaire.
Brimonidine tartrate Pharmacologie
Brimonidine diminue significativement la pression intraoculaire avec des effets minimes sur les paramètres cardiovasculaires et pulmonaires. Il abaisse la pression intraoculaire en diminuant la production d'humeur aqueuse et en augmentant l'écoulement uvéoscléral.
Brimonidine tartrate Absorption
Une faible absorption systémique ne se produit après l'insertion oculaire.
Brimonidine tartrate Toxicite
DL50 orale est de 50 mg / kg chez la souris et 100 mg / kg chez le rat.
Brimonidine tartrate Information pour les patients
PATIENT INFORMATION
Brimonidine tartrate is used for the treatment of open-angle glaucoma and ocular hypertension. Do not take this drug if you are currently taking MAO Inhibitors (e.g., Parnate). Inform your doctor if you are pregnant or nursing.
This product may stain soft contact lenses. Wait at least 15 minutes after instilling brimonidine to insert contact lenses.
May cause drowsiness or tiredness; use caution while driving or operating hazardous machinery. May cause dry mouth, blurring, stinging, or burning of the eyes; headaches, fatigue or drowsiness; allergic or itching of the eyes. Tell your doctor or pharmacist if these effects occur.
Brimonidine tartrate is used for the treatment of open-angle glaucoma and ocular hypertension. Do not take this drug if you are currently taking MAO Inhibitors (e.g., Parnate). Inform your doctor if you are pregnant or nursing.
This product may stain soft contact lenses. Wait at least 15 minutes after instilling brimonidine to insert contact lenses.
May cause drowsiness or tiredness; use caution while driving or operating hazardous machinery. May cause dry mouth, blurring, stinging, or burning of the eyes; headaches, fatigue or drowsiness; allergic or itching of the eyes. Tell your doctor or pharmacist if these effects occur.
Brimonidine tartrate Organismes affectes
Les humains et autres mammifères
